{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:40Z","timestamp":1787026840097,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.01041","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:59:14Z","timestamp":1544057954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Impulse Control Disorders and Dopamine-Related Creativity: Pathogenesis and Mechanism, Short Review, and Hypothesis"],"prefix":"10.3389","volume":"9","author":[{"given":"Pedro J.","family":"Garcia-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson's disease: recent advances","volume":"24","author":"Voon","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/WNF.0b013e31826e6e6d","article-title":"Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease","volume":"35","author":"Perez-Lloret","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson's disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","article-title":"The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: a cross-sectional multicenter study","volume":"368","author":"Vela","year":"2016","journal-title":"J Neurol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Parkinson's Progression Markers Initiative. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/cjn.2016.307","article-title":"Recurrent impulse control disorder associated with rasagiline treatment of Parkinson's disease","volume":"44","author":"Levy","year":"2017","journal-title":"Can J Neurol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.parkreldis.2016.03.014","article-title":"Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease","volume":"28","author":"Ricciardi","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.sleep.2018.02.004","article-title":"Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study","volume":"48","author":"Marques","year":"2018","journal-title":"Sleep Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","article-title":"Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas","volume":"34","author":"Martinkova","year":"2011","journal-title":"Clin Neuropharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mds.26587","article-title":"Emotional manifestations of PD: neurobiological basis","volume":"31","author":"Castrioto","year":"2016","journal-title":"Mov Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.07.010","article-title":"Dyskinesias and impulse control disorders in Parkinson's disease: from pathogenesis to potential therapeutic approaches","volume":"56","author":"Jim\u00e9nez-Urbieta","year":"2015","journal-title":"Neurosci Biobehav Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jare.2017.09.004","article-title":"Impulse control disorder and response-inhibition alterations in Parkinson's disease","volume":"8","author":"Jim\u00e9nez-Urbieta","year":"2017","journal-title":"J Adv Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/mds.23177","article-title":"Clozapine for medication-related pathological gambling in Parkinson disease","volume":"25","author":"Rotondo","year":"2010","journal-title":"Mov Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/JCP.0b013e31802e98c3","article-title":"Quetiapine in a case with Parkinson disease and pathological gambling","volume":"27","author":"Sevincok","year":"2007","journal-title":"J Clin Psychopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.parkreldis.2011.03.003","article-title":"Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease","volume":"17","author":"Hicks","year":"2011","journal-title":"Parkinson Relat Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2147\/NDT.S54423","article-title":"Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders","volume":"10","author":"Cera","year":"2014","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1017\/S104161021600096X","article-title":"Management of impulse control disorders in Parkinson's disease","volume":"28","author":"Zhang","year":"2016","journal-title":"Int Psychogeriatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00415-018-8803-1","article-title":"EDIS Study Group. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease","volume":"265","author":"Catalan","year":"2018","journal-title":"J Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00415-016-8314-x","article-title":"Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease","volume":"264","author":"Merola","year":"2017","journal-title":"J Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2017.01.019","article-title":"Management of impulse control disorders with deep brain stimulation: a double-edged sword","volume":"374","author":"Kasemsuk","year":"2017","journal-title":"J Neurol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/s-0037-1601887","article-title":"Impulse control disorders and related complications of Parkinson's disease therapy","volume":"37","author":"Lopez","year":"2017","journal-title":"Semin Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1046\/j.1360-0443.1998.93913758.x","article-title":"Familial influences on gambling behavior: an analysis of 3359 twin pairs","volume":"93","author":"Eisen","year":"1998","journal-title":"Addiction"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.0000000000003177","article-title":"Impulsive-compulsive behaviors in Parkin-associated Parkinson disease","volume":"87","author":"Morgante","year":"2016","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.parkreldis.2011.10.019","article-title":"Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders","volume":"18","author":"Vallelunga","year":"2012","journal-title":"Parkinson Relat Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/sjop.12113","article-title":"Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms","volume":"55","author":"Ziegler","year":"2014","journal-title":"Scand J Psychol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12640-014-9504-x","article-title":"The addiction-related gene ANKK1 in Parkinsonian patients with impulse control disorder","volume":"27","author":"Hoenicka","year":"2015","journal-title":"Neurotox Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","article-title":"Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients","volume":"30","author":"Krishnamoorthy","year":"2016","journal-title":"Parkinson Relat Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.parkreldis.2018.01.010","article-title":"Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants","volume":"49","author":"Castro-Mart\u00ednez","year":"2018","journal-title":"Parkinson Relat Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.parkreldis.2014.05.014","article-title":"Impulse control and related disorders in Mexican Parkinson's disease patients","volume":"20","author":"Rodr\u00edguez-Violante","year":"2014","journal-title":"Parkinson Relat Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00415-009-5001-1","article-title":"Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity","volume":"256","author":"Kulisevsky","year":"2009","journal-title":"J Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1468-1331.2011.03546.x","article-title":"Artistic productivity and creative thinking in Parkinson's disease","volume":"19","author":"Canesi","year":"2012","journal-title":"Eur J Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1037\/a0031052","article-title":"The awakening of artistic creativity and Parkinson's disease","volume":"127","author":"Inzelberg","year":"2013","journal-title":"Behav Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2014.00055","article-title":"Dopamine and the biology of creativity: lessons from Parkinson's disease","volume":"5","author":"Lhomm\u00e9e","year":"2014","journal-title":"Front Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24181","article-title":"Enhanced creative thinking under dopaminergic therapy in Parkinson disease","volume":"75","author":"Faust-Socher","year":"2014","journal-title":"Ann Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JPD-150681","article-title":"Creative thinking, professional artists, and Parkinson's disease","volume":"6","author":"Canesi","year":"2016","journal-title":"J Parkinsons Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01041\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:59:16Z","timestamp":1544057956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01041\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":43,"alternative-id":["10.3389\/fneur.2018.01041"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.01041","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"article-number":"1041"}}